Nymox Pharmaceutical Corp
NYMX
NYMX was delisted on the 6th of July, 2023.
59 hedge funds and large institutions have $13.4M invested in Nymox Pharmaceutical Corp in 2021 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 21 increasing their positions, 13 reducing their positions, and 3 closing their positions.
246% more call options, than puts
Call options by funds: $45K | Put options by funds: $13K
62% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 13
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
2% more funds holding
Funds holding: 58 → 59 (+1)
0.19% more ownership
Funds ownership: 7.47% → 7.65% (+0.19%)
7% less capital invested
Capital invested by funds: $14.3M → $13.4M (-$930K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$505K |
| 2 |
BlackRock
New York
|
+$167K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$133K |
| 4 |
State Street
Boston,
Massachusetts
|
+$133K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$66.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$168K |
| 2 |
Morgan Stanley
New York
|
-$94.8K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$76.2K |
| 4 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$65.9K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$54.3K |
NYMX Hedge Fund Activity: Q1 2021 in Review
59 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Nymox Pharmaceutical Corp (NYMX) for Q1 2021, worth a combined $13.4M — down 6.5% from $14.3M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new NYMX positions and 3 closed out — a net gain of 1 holder — while 21 added to existing stakes and 13 trimmed.
The largest buyer was Wells Fargo, adding an estimated $505K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $168K sold.
- 59 institutional investors held Nymox Pharmaceutical Corp (NYMX) as of Q1 2021, up from 58 in Q4 2020.
- Funds reported $13.4M of Nymox Pharmaceutical Corp stock for Q1 2021, down 6.5% quarter-over-quarter.
- 4 funds opened new Nymox Pharmaceutical Corp positions in Q1 2021 and 3 closed out, a net change of +1 holder.
- The largest Nymox Pharmaceutical Corp buyer in Q1 2021 was Wells Fargo, an estimated $505K added.
- The largest Nymox Pharmaceutical Corp seller in Q1 2021 was Renaissance Technologies, an estimated $168K sold.
Based on aggregated 13F filings for Q1 2021.